Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.
about
Hepatitis C Virus, Insulin Resistance, and SteatosisExtrahepatic manifestations of chronic hepatitis C virus infectionMetabolic alterations and hepatitis C: From bench to bedsidePathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenValue of Treating All Stages of Chronic Hepatitis C: A Comprehensive Review of Clinical and Economic EvidencePotential role of Hedgehog pathway in liver response to radiationThe association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent.Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearanceEndoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulationInsulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.Diabetes and Hepatitis C: A Two-Way Association.Retrospective study of the associations between hepatitis C virus infection and metabolic factors.New insights into HCV-related rheumatologic disorders: A review.Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review.Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review.PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.Daclatasvir for the treatment of chronic hepatitis C.The role of insulin resistance in nonalcoholic steatohepatitis and liver disease development--a potential therapeutic target?Metabolic and Cardiovascular Complications in HIV/HCV-Co-infected Patients.Impact of hepatitis C virus therapy on metabolism and public health.Association between interferon use and reduced metabolic and vascular complications among patients with hepatitis C.Insulin resistance, steatosis and hepatitis C virus.Ten-year follow-up analysis of chronic hepatitis C patients after getting sustained virological response to pegylated interferon-α and ribavirin therapy.Diabetes and Cirrhosis Are Risk Factors for Hepatocellular Carcinoma After Successful Treatment of Chronic Hepatitis C.Factors Associated with Insulin Resistance in Patients with Chronic HCV Genotype 1 Infection without Obesity or Type 2 Diabetes.HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients.Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance.SIGNIFICANT IMPROVEMENT OF GLYCAEMIC CONTROL IN DIABETIC PATIENTS WITH HCV INFECTION RESPONDING TO DIRECT-ACTING ANTIVIRAL AGENTS.Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.Does telaprevir possess a direct antidiabetic effect?Are metabolic factors still important in the era of direct antiviral agents in patients with chronic hepatitis C?Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.Study of changes in lipid profile and insulin resistance in Egyptian patients with chronic hepatitis C genotype 4 in the era of DAAs.
P2860
Q26751755-433729B9-158F-4E65-8B87-2D627FDA39E7Q26767084-2DA5C74A-322F-46B9-8124-5356D3604BD2Q26773261-7EEC566B-62D1-4378-B7D4-84F8259FE198Q26861095-58B683EA-7C39-4E10-85E2-EE7B8DDB7BB9Q28072257-A446E86E-D203-4894-A263-66A624A3A1ECQ28533455-E338699C-3D2D-4DA4-A178-E2CDCD5B8DDAQ33755525-F1356457-9C76-4D28-AD41-05D2B41424C4Q34046758-6ABACD9D-1EFD-48CB-84A3-B6B78113005DQ34057855-D000F381-594E-4138-B43E-6DF9BC6E055CQ34467208-7652E8FC-4BC5-4855-8AEE-4094AEDA5BBDQ36056076-764AF9DA-18E5-49D0-A118-D0DF75BBDE74Q37374053-8D38F28C-7CF7-4D2D-84EC-62219FB460A5Q37610871-2DB73A21-05DC-466F-BC6A-2563D1CBE84FQ37610878-1138A299-CED4-4471-BA9F-C305CC39BB7BQ37685491-BFFFAF22-2318-4ED3-93E9-3BA7DD5D6796Q38102776-45E71BFC-FC7E-4D87-A568-6A3E6622B237Q38628237-4647E6DB-48E8-4C53-B7C6-7AAE158D2D1CQ38660769-6A5A130B-9DF4-432F-96BE-E6A978AF9AFAQ38946641-C31F6F90-9B1C-4A57-8CEC-4F1F4327E6E8Q39040729-E074078F-C259-4D3B-870A-C06A458FD554Q39146830-8667F4D1-831E-4985-AD3D-C2559BB4821FQ39240971-A4DEC661-6F66-4F3A-BEC2-E176D7564276Q39564809-32F111E2-B759-4DDC-B63A-21B9378CFA81Q39695580-547548CB-1F2E-487F-A1FE-CB205F13E875Q39954657-535F2331-7959-4183-8ADA-8B268A1442DAQ40486607-2175F781-C888-43CE-92DE-054E402D6606Q41375331-69A67161-338D-4DC3-B912-F4D2106CD22DQ41928201-3B6F104D-45AD-45B4-BC0B-09E64F4F39CDQ42245782-12257AFE-A582-440E-96B8-E12CE3919DD9Q42249687-5516A2B2-609D-46E8-81E1-D2E2988659CDQ42919523-BEA4C712-F397-4074-8139-90293832EDF4Q43136598-6F26D1BD-D411-4853-8735-7520C9FABA19Q49942281-4153B8CE-2F99-4A2A-9B46-5E2C8E9BB98C
P2860
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sustained virological response ...... ents with chronic hepatitis C.
@en
Sustained virological response ...... ents with chronic hepatitis C.
@nl
type
label
Sustained virological response ...... ents with chronic hepatitis C.
@en
Sustained virological response ...... ents with chronic hepatitis C.
@nl
prefLabel
Sustained virological response ...... ents with chronic hepatitis C.
@en
Sustained virological response ...... ents with chronic hepatitis C.
@nl
P2093
P2860
P50
P356
P1433
P1476
Sustained virological response ...... ients with chronic hepatitis C
@en
P2093
Gian Maria Prati
Massimo Colombo
Roberta Soffredini
Stella De Nicola
Valeria Grancini
P2860
P304
P356
10.1002/HEP.25867
P407
P577
2012-10-14T00:00:00Z